Stratec SE (STSEY)
OTCMKTS · Delayed Price · Currency is USD
4.990
0.00 (0.00%)
At close: Feb 5, 2026
Stratec SE Revenue
Stratec SE had revenue of 57.00M EUR in the quarter ending September 30, 2025, a decrease of -5.42%. This brings the company's revenue in the last twelve months to 260.25M, up 1.78% year-over-year. In the year 2024, Stratec SE had annual revenue of 257.62M, down -4.73%.
Revenue (ttm)
260.25M EUR
Revenue Growth
+1.78%
P/S Ratio
0.97
Revenue / Employee
183.28K EUR
Employees
1,420
Market Cap
294.96M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 257.62M | -12.79M | -4.73% |
| Dec 31, 2023 | 270.41M | -4.21M | -1.53% |
| Dec 31, 2022 | 274.63M | -12.71M | -4.42% |
| Dec 31, 2021 | 287.34M | 37.24M | 14.89% |
| Dec 31, 2020 | 250.10M | 35.94M | 16.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| OpGen | 9.00M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.41M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |
Stratec SE News
- 3 months ago - Stratec SE ADR (STSEY) Q3 2025 Earnings Call Transcript - Seeking Alpha